Walgreens Boots Alliance, Inc.

I will be your conference operator today. At this time, I would like to welcome everyone to the Walgreens Root Boots Alliance Incorporated fourth quarter and fiscal year 2023 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. And if you would like to withdraw your question, please press star one. Thank you. Tiffany Kanega, Vice President of Global Investor Relations, you may begin your conference.

Good morning. Thank you for joining us for the Walgreens Boots Alliance earnings call for the fourth quarter of fiscal year 2023. I'm Tiffany Kanega, Vice President of Global Investor Relations. Joining me on today's call are Ginger Graham, our Interim Chief Executive Officer, Manmohan Mahajan, our Interim Global Chief Financial Officer, and John Driscoll, President of U.S. Healthcare. In addition, Rick Gates, Senior Vice President and Chief Pharmacy Officer at Walgreens, and Tracy Brown, President of Walgreens Retail and Chief Customer Officer, will participate in Q&A. All references to the COVID-19 headwind on today's call include U.S. vaccines, drive-through tests, and OTC tests. As always during the conference call, we anticipate making projections and forward-looking statements based on our current expectations. Our actual results could differ materially due to a number of factors, including those listed on slide two and those outlined in our latest Form 10-K filed with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement after this presentation, whether as a result of new information, future events, changes in assumptions, or otherwise. You can find our press release and the slides referenced on this call in the investor section of the Walgreens Boots Alliance website. The slides in the press release also contain further information about the non-GAAP financial measures that we will discuss during this call. I will now turn the call over to Ginger.

Thanks, Tiffany, and good morning, everyone. The good news you heard yesterday is that Tim Wentworth has agreed to join WBA as our new Chief Executive Officer, effective October 23rd. We're thrilled to have Tim and believe he will make a meaningful contribution to the future of the company with his deep knowledge and expertise in healthcare. We've asked him to make a few comments this morning, and I would like to turn it over to him now. Tim?